In a very recent multicentric cohort study, Dima et al.[42] found that anti-NOR90+ SSc patients were more frequently female, had lower mRSS, and lower prevalence of gastrointestinal symptoms respect to anti-NOR90 negative individuals. The gene discussed is UBTF; the disease is systemic sclerosis.